Can Your MELD Score Decrease?

MELD scores can and do decrease, sometimes substantially. Because the score is calculated from three blood tests that reflect how your liver and kidneys are functioning right now, anything that improves those lab values will pull the number down. How much it drops, how quickly, and whether the improvement reflects genuine recovery or just a lab artifact depends entirely on what caused the liver damage in the first place and what treatment you receive.

What Feeds Into the Number

The MELD score is built from three lab values: serum bilirubin (a waste product the liver clears), serum creatinine (a marker of kidney function), and the international normalized ratio, or INR (a measure of how well your blood clots). Since 2002, transplant programs worldwide have used this score to rank patients on the waiting list so that the sickest patients get organs first, regardless of how long they have been waiting.¹ Higher numbers mean worse liver function. The scale runs from 6 to 40 in practice, and because it is recalculated every time fresh labs are drawn, the score is inherently dynamic. It can climb, plateau, or fall.

This is the critical point for anyone watching their own number: the MELD score is not a permanent stamp. It is a snapshot. If your liver and kidneys start working better for any reason, the three inputs improve and the score goes down. The question worth asking is not really “can it decrease?” but “under what circumstances does it decrease, and what does the drop actually mean?”

Alcohol-Related Liver Disease and the Power of Abstinence

The most dramatic MELD score declines tend to occur in people whose liver damage is driven by alcohol. The liver has a remarkable capacity to heal when the ongoing insult is removed, and stopping drinking is the single most effective intervention for this population. In a study of 420 patients with alcohol-related decompensated cirrhosis on a transplant waiting list, about 9% were eventually delisted because they improved enough that a transplant was no longer necessary. Their MELD scores started dropping noticeably within six months of being listed.² Getting delisted for improvement is relatively uncommon, but it happens, and it almost always involves sustained sobriety.

For people with severe alcohol-associated hepatitis who are not candidates for an immediate transplant, recovery is harder but still possible. In one cohort of patients denied early transplantation, roughly a quarter experienced spontaneous recovery. Younger age, lower INR at baseline, and a lower peak MELD score all predicted a better chance of bouncing back.³ Still, only about one in five of those who recovered reached what doctors would consider a truly compensated state, with a MELD below 15 and no ongoing treatment for complications like fluid buildup or confusion.³ So while the score can fall, getting it all the way back to a comfortable range is a much steeper climb.

Medications that help people stay sober may contribute indirectly by keeping the liver free from further damage. One study of baclofen, used to maintain abstinence in patients with alcoholic hepatitis, found that liver enzymes, bilirubin, INR, and MELD scores all dropped after treatment compared to baseline.⁴ The medication itself does not treat the liver; it works by reducing cravings. But staying sober lets the liver do its own repair work, and that repair shows up as a falling MELD score.

Treating Viral Hepatitis

If your liver disease is caused by hepatitis B or C, antiviral treatment is one of the most reliable ways to bring your MELD score down. These infections cause ongoing inflammation and scarring, and eliminating or suppressing the virus allows the liver to recover some lost ground.

For hepatitis C, the arrival of direct-acting antiviral drugs transformed the outlook. A systematic review and meta-analysis of patients with hepatitis C-related decompensated cirrhosis found that the average MELD score dropped by nearly 8 points after treatment.⁵ That is a substantial shift. For someone with a MELD of 25, dropping to the high teens could mean the difference between urgent transplant status and stable enough to wait comfortably.

Hepatitis B treatment tells a similar story, though the improvements tend to be more gradual because the virus is suppressed rather than cured. In a cohort of patients with hepatitis B-related cirrhosis on antiviral therapy, the average MELD score fell from about 12 to 11 within six months.⁶ That may sound modest, but among the broader group studied, nearly half of patients who survived without transplant achieved a drop of more than 5 points over time.⁷ Another 30% saw a smaller improvement of 1 to 5 points. So the majority of hepatitis B patients on treatment see at least some downward movement.

When Kidney Treatment Lowers the Score Without Fixing the Liver

Here is where things get tricky. Because serum creatinine is one of the three inputs to the MELD calculation, anything that improves kidney function will pull the score down, even if the liver itself is no better. This matters most in hepatorenal syndrome, a dangerous condition where failing liver function drags the kidneys down with it.

Medications like terlipressin can reverse hepatorenal syndrome and bring creatinine back toward normal. The problem is that the falling MELD score in this situation may overstate how well the patient is actually doing. Improving kidney numbers without improving liver function means the patient looks healthier on paper but may still be critically ill. This discrepancy has led some researchers to suggest that when hepatorenal syndrome responds to treatment, the MELD score used for transplant allocation should be based on the pre-treatment value rather than the post-treatment one.⁸ It is an ongoing debate, and transplant centers handle it differently, but the core issue is real: a lower number does not always mean you are doing better.

The same logic applies in the other direction. Creatinine can be misleadingly low in patients with severe cirrhosis because they have lost so much muscle mass. Less muscle means less creatinine production, so the blood level looks normal even when the kidneys are struggling. This makes the MELD score appear lower than it should be, potentially underestimating how sick the person actually is.⁹ If you gain weight, improve nutrition, or regain some muscle, creatinine may actually rise and push your MELD up, even though your overall health is improving.

Drug-Induced Liver Injury and Other Reversible Causes

Not all liver disease is chronic. Medications, supplements, and herbal products can all damage the liver, sometimes severely enough to send MELD scores climbing into transplant-eligible territory. The encouraging news is that most cases of drug-induced liver injury are self-limiting: once the offending substance is removed, the liver recovers on its own.¹⁰ In these situations, the MELD score drops as bilirubin and INR normalize, sometimes within weeks.

Autoimmune hepatitis presents a slightly different picture. In acute severe cases, doctors typically try corticosteroids to tamp down the immune attack on the liver. One study of this approach found that among treated patients, there was no clear difference in MELD scores between those who responded to steroids and those who did not.¹¹ That does not mean steroids never help, but MELD alone was not the metric that separated responders from non-responders in that study. For autoimmune hepatitis that does respond to immunosuppression, the score can improve over time, though the trajectory tends to be slower and less dramatic than what you see with alcohol abstinence or antiviral therapy for hepatitis C.

Biliary obstruction, where a blockage prevents bile from draining out of the liver, is another reversible cause of an elevated MELD. When a bile duct is blocked by a gallstone or a tumor, bilirubin skyrockets and takes the MELD with it. Placing a stent or clearing the obstruction can bring bilirubin down quickly, causing a steep drop in the score even though the underlying disease (if it is a cancer, for example) has not changed.

Lab Variability and Phantom Score Changes

Some MELD score changes are not real. They are artifacts of how the labs are measured. This is one of the most underappreciated aspects of the scoring system, and it can genuinely affect transplant allocation.

The INR, which measures clotting speed, is notoriously inconsistent from one laboratory to another. A study that sent identical blood samples to multiple labs found that the resulting INR values varied widely. For a single sample, one lab might report an INR of 1.2 while another reported 2.0. When those numbers were plugged into the MELD formula, calculated scores ranged from 8 to 14 for the same patient on the same day. At higher levels of liver dysfunction, the gap widened to as much as 9 points, with one sample yielding MELD scores from 16 to 25 depending on the lab.¹² Simply switching where your blood is drawn can make your score appear to rise or fall by several points.¹³

Creatinine measurements add another layer of noise. Different assay methods used to measure creatinine can disagree substantially, and the disagreement gets worse when bilirubin is very high. In patients with bilirubin above a certain threshold, creatinine-driven MELD variation reached as much as 7 points. When the MELD was already 25 or above, the average score could swing by 2 to 3 points just from the choice of creatinine assay.¹⁴ If you see a small drop in your score between visits, the change may be entirely explained by lab-to-lab variation rather than any real change in your condition.

The practical takeaway: if your score moves by a couple of points from one blood draw to the next, do not read too much into it. Ask whether the labs were run at the same facility, and look at the trend over multiple measurements rather than any single result.

What a Dropping Score Means for Your Place on the Transplant List

For someone on the liver transplant waiting list, a falling MELD score creates an uncomfortable paradox. You are getting healthier, which is good. But your priority for a new liver is also dropping, which could leave you in a dangerous middle zone: too sick to live normally, but not sick enough to get an organ in time.

This tension is especially relevant for hepatitis C patients. Curing the virus before transplant clearly improves quality of life and reduces the risk of liver cancer over time. But researchers have flagged a genuine dilemma: treating hepatitis C before transplant can lower the MELD score enough that the patient loses waitlist priority, potentially delaying or preventing the transplant they still need.¹⁵ In some cases, the smarter strategy may be to treat the hepatitis C after transplant, when the new liver gets the benefit of the cure without the patient losing their place in line. The decision depends on how high the MELD score is, how fast organs are becoming available in the patient’s region, and how rapidly the liver disease is progressing.

A similar calculus applies to hepatorenal syndrome treatment, as discussed earlier. If terlipressin brings your creatinine down, your MELD drops, and transplant programs may reclassify you as lower priority, even if your liver is still in serious trouble. Some transplant centers address this with exception points, essentially arguing to the regional review board that the calculated MELD underrepresents the patient’s true severity. But the process is inconsistent and depends on the center and the region.

Does the Direction of Change Predict the Future?

Doctors sometimes track not just the MELD score itself but how it is changing over time. The intuition makes sense: a stable score of 18 and a score of 18 that was 12 three months ago tell very different stories. Researchers have studied this by looking at “delta MELD,” the change in score over a defined period.

One study found that a delta MELD of more than 2.5 points per month was the strongest predictor of death at both 6 and 12 months, outperforming the raw MELD score and the older Child-Turcotte-Pugh classification.¹⁶ That is a rapidly climbing score, and it signals accelerating liver failure. By contrast, a separate analysis of transplant waiting-list patients found that while delta MELD was somewhat predictive of death on its own, its usefulness diminished once the current MELD score was already factored in. The current score was the single most important predictor of who would die on the waiting list, and the rate of change added little to the picture except in the days immediately before death.¹⁷

The practical reading here: a declining MELD score is generally encouraging, and a rapidly rising one is alarming. But the most recent value matters more than the trajectory. If your score has dropped from 22 to 16 over the past six months, that reflects real improvement. If it was 16 yesterday, that is what best describes your risk right now, regardless of where it has been.

Weight Loss, Lifestyle Changes, and the Limits of What Moves the Number

People with cirrhosis related to fatty liver disease sometimes wonder whether losing weight can bring their MELD score down. The answer, so far, is disappointing. A study of weight-loss medications in patients with cirrhosis found no meaningful effect on MELD scores, even when patients lost weight.¹⁸ Weight loss did not independently change the score. This does not mean lifestyle changes are useless for people with fatty liver disease, because other markers of liver health and inflammation can improve, and preventing further damage matters. But the MELD score specifically does not seem to respond to weight loss in the way you might hope.

This makes sense when you remember what the score actually measures. Bilirubin, creatinine, and INR are downstream indicators of how well the liver and kidneys are functioning at a given moment. Losing weight addresses the upstream cause (fat accumulation in the liver) but by the time cirrhosis has set in, the damage may be too advanced for weight loss alone to meaningfully improve those particular lab values. The MELD score was designed to predict short-term mortality, not to track the slow metabolic improvements that come from lifestyle changes.

When a Lower Score Is Not Really Good News

It is worth sitting with the uncomfortable fact that not every MELD decrease means things are getting better. Beyond the lab variability and kidney-treatment artifacts already discussed, there are a few other scenarios where a dropping score can mislead.

Severe muscle wasting, which is common in advanced cirrhosis, reduces creatinine production. As patients become more malnourished and lose muscle, their creatinine falls, pulling the MELD down. The patient is sicker, not healthier. Similarly, blood transfusions can temporarily normalize INR, and aggressive fluid management can dilute bilirubin, all creating the appearance of improvement that does not last.

If your MELD score drops by a point or two between appointments, consider what else has changed. Did you switch labs? Were you dehydrated at the last draw and well-hydrated this time? Did you start or stop a medication that affects the kidneys? Small fluctuations in either direction are noise. The signal comes from sustained, consistent trends measured under similar conditions, ideally at the same lab with the same assays each time.